Navigation Links
Reportlinker Adds What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015
Date:6/6/2011

s

Current Products

CHAPTER FOUR: BIOPHARMACEUTICAL PIPELINES

Overview

Biopharmaceutical Development Outlook

Company R&D Profiles

Abbott

Amgen

Biogen Idec

Bristol-Myers Squibb

Eli Lilly

GlaxoSmithKline

Merck KGaA

Novartis

Novo Nordisk

Pfizer

Roche

CHAPTER FIVE: ISSUES AND TRENDS

Overview of the Industry

The Next Generation of Biologics

Technology for Drug Adherence, Targeted Delivery and Monitoring

Government Incentives for Biologic Development

Biopharmaceutical and Biosimilar Drug Development

Clinical Trial Costs

Orphan Drugs

Pharmaceutical Regulatory Exclusivity

Pediatric Extensions

Biopharmaceutical Industry—Biosimilar (Biogeneric) Development and Exclusivity

Aging Population

Healthcare Expenditures Growth

Health Care Reform's Impact on Biopharmaceutical Companies

Mergers, Acquisitions, and Collaborations

Contributors To R&D Success

R&D Spending

Cancer Drugs in Development 2011

The Impact of Targeted Therapy in Oncology

Genome Sequencing for Personalized Healthcare

The Role of Contract Research Organizations

Global Expansion

CHAPTER SIX: MARKET SUMMARY

Market Overview

Biopharmaceutical Product Analysis

Market Forecast

Geographical Analysis

Competitor Analysis

Company Analysis by Therapeutic Segment

CHAPTER SEVEN: COMPANY PROFILES

Introduction

Abbott Laboratories, Inc

Amgen, Inc.

Biogen Idec

Johnson & Johnson

Merck & Co., Inc.

Merck Serono

Novo Nordisk

Pfizer

Roche/Genentech

Sanofi-Aventis/Genzyme

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1 Global Biopharmaceutical Treatm
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... (PRWEB) April 30, 2015 Available ... at http://www.lespausa.com , Fleur’s ... product combining the benefits of makeup, skin care ... subtly tinted cream is designed with specific complexion-correcting ... an even complexion and a healthy glow. Far ...
(Date:4/30/2015)... Cordova, CA (PRWEB) April 30, 2015 ... announced that Julie I. Morris has joined SureClinical’s executive ... is an experienced biotech and technology executive with over ... large Fortune 500 companies. , Ms. Morris joins ... ag biotech company. She was CFO of MBI from ...
(Date:4/30/2015)... 2015 Sterlitech is proud to ... PX, PY, and PZ Polyacrylonotrile (PAN) membranes ... Designed to be ideal for oil removal ... fill critical process requirements where the presence of ... “New regulations on industrial wastewater discharge and quality ...
(Date:4/29/2015)... BELLINGHAM, Washington, and BALTIMORE, Maryland, USA (PRWEB) April 29, ... premier event for photonics, optical sensing, and imaging on ... a place for government program managers, researchers, applications developers, ... and technology of sensing and imaging for multiple applications. ... -- defense and security, and commercial and scientific sensing ...
Breaking Biology Technology:Fleur’s Introduces CC CRÈME Perfect Skin Solution 2Fleur’s Introduces CC CRÈME Perfect Skin Solution 3Julie I. Morris Joins SureClinical as Chief Financial Officer 2Sterlitech Offers New Ultrafiltration Membranes 2SPIE DSS provides venue for collaboration vital to research, applications advances 2SPIE DSS provides venue for collaboration vital to research, applications advances 3SPIE DSS provides venue for collaboration vital to research, applications advances 4
... CGCP), announced that the company will release results,for ... to market open on,Wednesday, November 14, 2007. The ... Senior Vice President and Chief Financial Officer William ... day at 12:00 p.m. Eastern,time (9:00 a.m. Pacific ...
... Oct. 24 Cell Therapeutics,Inc. (CTI) (Nasdaq ... at,the 19th annual AACR-NCI-EORTC Symposium show its ... refractory to currently,marketed platinum agents carboplatin, cisplatin ... trials in late 2008. "Bis-platinates represent ...
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) ... of approval from the U.K. Medicines and ... Trial Application (CTA) to begin,a clinical trial ... cyclophosphamide, a chemotherapeutic agent as well as,immune ...
Cached Biology Technology:Cardiogenesis Corporation to Report Third Quarter 2007 Results on November 14th 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 3Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide 2Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide 3
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, the ... users across iOS and Android ... integrating biofeedback into the platform to allow patients to ... For the first time, patients will be able to ... dose impacts important biometrics, such as glucose levels and ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... of the "Global Iris Recognition Market 2015-2019" ... the Global Iris Recognition market to grow at a ... This report covers the present scenario and the ... the period 2015-2019. To calculate the market size, the ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs , ... company, today announced that the Company will demonstrate multiple ... enterprise and consumers at Connect:ID on March 23 through ... HOYOS Labs will highlight the IEEE Biometric Open Protocol ... ; and enterprise access control system. BOPS was invented ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... of how plants "breathe" may help us breed and select ... of Toronto study. , The paper, which offers the first ... surface pores, appears in the July 12 issue of Current ... and senior author Malcolm Campbell. "This is a gene that ...
... intense selective logging stopped in the region now ... guenon (Cercophithecus ascanius) is a primate still in ... new study, changed the ecological balance for these ... door for multiple parasitic infections. , The researchers ...
... sneak past the blood brain barrier, which protects the brain ... particularly invasive brain cancer, according to a new Saint Louis ... Academy of Sciences Online Early Edition the week of Aug. ... drugs into the brain, you can cure brain cancer," says ...
Cached Biology News:Genetic discovery could lead to drought-resistant plants 2Logging changed ecological balance for monkeys, damaged health 2Logging changed ecological balance for monkeys, damaged health 3Slipping past the blood brain barrier: Research shows potential treatment for brain cancer 2
... CYCLES. This kit allows the quantitation of ... DNA affinity-mediated capture of free nucleosomes followed ... mono- and oligonucleosomes are captured on pre-coated ... antibody then binds to the histone component ...
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
OmniSlide Heated Wash Module. 2 independent chambers with precise temperature control from ambient of 5C to 70C. Each chamber holds 1 slide rack (20 slides). Includes 2 x Wash Sleeves, 1 x Slide R...
HIV Reverse Transcriptase provides an excellent target for evaluating antiviral agents or catalyzing error prone synthesis on RNA and DNA templates....
Biology Products: